To no one’s surprise, COVID-19 has pushed the country into a designated recession. While keeping a careful watch on public health and safety, government officials and economic leaders are now fervently seeking ways to boost America’s economy and to support job creation.
The path out of this recession, according to many fiscal policy experts, is clear. It is through improvements to infrastructure – transportation, water, power, technology, airports, and social infrastructure (vertical construction). Addressing those critical needs will stimulate the economy and create jobs immediately. Regional leaders throughout America know how to prioritize critical infrastructure needs – they just need encouragement and funding.
Unfortunately, when it comes to infrastructure, America is more than 30 years behind numerous other countries. Many argue that we are behind because of a lack of revenue, but that’s simply not the case. Funding for critical infrastructure projects is available from dozens of sources. The lacking component is leadership, and that is required from many sources.
Government officials can point to the greatest of these unmet needs, and the time is long past for the media at large to step up and report on this issue consistently and accurately. The public at large needs to understand that the greatest costs will result from not addressing critical infrastructure problems. The result of continued inattention will soon begin to impact every American.
China has demonstrated it can build a new bridge in less than 43 hours. We can’t do that! Other countries have their airports listed in the top 10 global rankings. America is not there. More than 56,000 U.S. bridges are classified as structurally unsound, and that statistic has not changed in years. Clean drinking water is compromised in too many parts of the country, broadband does not reach many rural areas, and many of America’s power grids and water pipelines are decades past their anticipated lifespan in many parts of America. Those infrastructure issues are dangerous.
The good news, however, is that entrepreneurship is alive and well in America. Technology, innovation, collaboration, and funding – everything required to reverse the infrastructure crisis – is available in abundance. A Deloitte report outlines a $2.1 trillion funding deficit linked to infrastructure. The projected costs escalate continually.
The quickest way out of the newly designated recession is through infrastructure activity. The only thing lacking is leadership.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
How to create an Email marketing campaign your audience will love
Whether you sell a product or service, work from a home office or a corporate one, starting an email campaign...
Top 10 Forex Risks To Consider Before Starting Currency Trade
This article shows you the fx risk to expect while performing forex trade and how to mitigate them and ensure...
Why are investments in the fintech sector set to break records this year
The fintech sector has had a great year so far, according to investor Humberto Herrera Rincón Gallardo, who thinks that...
Biotech companies are getting closer to find the eagerly awaited COVID-19 vaccine
Moderna agreed to sell its coronavirus drug at a "pandemic price" of $32-37 per dose.The biotech company registered losses of...
Switzerland returns $35.6 million to cannabis light producers
Swiss companies producing light cannabis products have received $35.6 million (€30 million) from the customs authorities for illegal taxes previously...
Biotech6 days ago
The Spanish pharma sector increased its profit by 18.4% in the first semester of the year
Business6 days ago
The financial guide for newlywed millennials
Featured5 days ago
The Italian fintech company Fido closes a €1.1 million financing round
Business5 days ago
PR Tech: How investments in the media market changed?